LLY News and Press, Eli Lilly and Company From 12/18/23

2023-12-18 11:44:54 ET More on Eli Lilly Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly Eli Lilly and Company (LLY) Presents at 6th Evercore ISI HealthCONx Conference (Transcript) Eli Lilly: Perfectly Priced Healthcare Giant ...

2023-12-18 11:11:08 ET Summary The Health Care Select Sector SPDR Fund is a popular ETF that provides exposure to the healthcare sector. XLV has shown consistent performance and has outperformed the SPY ETF over the past decade. The ETF comprises major healthcare industry play...

2023-12-18 09:22:49 ET More on Lantheus, POINT Biopharma Global, etc. POINT Biopharma Global: Why The Market Believes That A Second Bidder May Emerge Lantheus Holdings: Huge Catalysts Ahead And Cheap Valuation Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Call Tran...

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023 PR Newswire INDIANAPOLIS , Dec. 18, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and ...

2023-12-16 14:00:00 ET Summary PFE has squandered the COVID-19 windfall by overpaying for Seagen, while contributing to the deterioration of its balance sheet and the eventual plunge in its stock prices. We believe that its inventory write-downs and goodwill amortization may accel...

2023-12-16 05:55:00 ET Seemingly bad news can sometimes be really good news. I think a recent study for Eli Lilly 's (NYSE: LLY) rival to Novo Nordisk 's massively successful Ozempic and Wegovy provides a great case in point. Results from the Surmount-4 clinical trial were p...

2023-12-15 11:34:09 ET Summary Celsius Holdings is a company that specializes in fitness drinks and is tapping into the health-conscious trend. The company's latest quarterly report shows strong financial performance, with a significant increase in revenue and net income. The ...

2023-12-14 12:25:24 ET Summary Biopharmaceutical sector valuations have become more attractive after a significant decline in 2021. Larger drug companies are making acquisitions and partnerships with small-cap stocks at generous premiums. Money managers are under-invested in t...

2023-12-14 10:17:11 ET More on S&P 500 Index: Powell Spikes The Punch Bowl - The Implications Fed Delivers Bullish Shock To Investors, All-In Trade On Significant 2024 Rate Cuts The Fed's Message To The Market Isn't What It Seems Nasdaq, S&P, Dow rise...

2023-12-14 09:10:00 ET Two of the biggest names in healthcare today are Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) . These companies have the most popular weight loss drugs available in the market right now. And that's a key reason why shares of these two companies...